Cartesian TherapeuticsRNAC
那斯達克 · USD
6.23
-0.52
(-7.70%)
盤中 05/27 02:14 (UTC+8)
05/27 02:14 (UTC+8)
Cartesian TherapeuticsRNAC
6.23
-0.52
(-7.70%)
財務數據
損益表
- 0.08
- 0.06
- 0.33
- 0.00
- -0.01
- 0.01
- 0.00
- 0.00
- 0.01
- 0.00
- 26.18
- -29.35
- 472.69
- -98.84
- -
- -
- -72.91
- 51.68
- 109.51
- -91.76
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 78 | 947 | 452 | 298 | 1,100 | -759 | 387 | 33,445 | 5,840 | 8,266 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 78 | 947 | 452 | 298 | 1,100 | -759 | 387 | 33,445 | 5,840 | 8,266 |
營業費用 | 26,577 | 79,586 | 21,518 | 22,109 | - | 18,393 | 17,962 | 19,688 | 19,188 | 44,598 |
研發費用 | 19,463 | 14,689 | 13,802 | 14,869 | 14,674 | 11,306 | 11,400 | 12,661 | 9,738 | 21,852 |
推銷及管理費用 | 7,114 | 8,197 | 7,716 | 7,240 | 8,315 | 7,087 | 6,562 | 7,027 | 9,450 | 22,036 |
非經常性項目費用 | - | 56,700 | - | - | - | - | - | - | - | 710 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -26,499 | -21,939 | -21,066 | -21,811 | -21,889 | -19,152 | -17,575 | 13,757 | -13,348 | -36,332 |
其他收入及費用 | -12,683 | -23,130 | -14,836 | 37,697 | 4,179 | - | -6,608 | 79 | -43,476 | -160,326 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -39,182 | -101,769 | -35,902 | 15,886 | -17,710 | -9,966 | -24,183 | 13,836 | -56,824 | -196,658 |
所得稅 | - | -9,193 | - | - | - | - | - | - | - | -19,000 |
稅後純益 | -39,182 | -92,576 | -35,902 | 15,886 | -17,710 | -10,253 | -24,183 | 13,836 | -56,824 | -177,658 |
基本每股稅後盈餘(元) | -1.46 | -3.47 | -1.38 | 0.51 | -0.68 | -3.58 | -1.13 | 0.58 | -0.35 | - |
稀釋每股稅後盈餘(元) | -1.46 | -3.57 | -1.38 | 0.50 | -0.68 | -10.03 | -0.73 | 6.62 | -0.35 | -1.39 |
基本平均股數(千股) | 26855.00 | 26009.00 | 26002.00 | 25980.00 | 25902.00 | 39813.00 | 21471.00 | 16723.00 | 162422.00 | - |
稀釋平均股數(千股) | 26855.00 | 25542.00 | 26002.00 | 26447.00 | 25902.00 | 39069.00 | 21471.00 | 17791.00 | 162422.00 | - |
還原基本每股稅後盈餘(元) | -1.46 | -3.47 | -1.38 | 0.51 | -0.68 | -3.58 | -1.13 | 0.58 | -10.50 | - |
還原稀釋每股稅後盈餘(元) | -1.46 | -3.57 | -1.38 | 0.50 | -0.68 | -10.03 | -0.73 | 6.62 | -10.50 | -41.56 |
還原基本平均股數(千股) | 26,855 | 26,009 | 26,002 | 25,980 | 25,902 | 39,813 | 21,471 | 16,723 | 5,414 | - |
還原稀釋平均股數(千股) | 26,855 | 25,542 | 26,002 | 26,447 | 25,902 | 39,069 | 21,471 | 17,791 | 5,414 | - |
EBITDA(千元) | -38,567 | -101,161 | -35,296 | 16,475 | -16,554 | -9,767 | -23,897 | 14,032 | -56,641 | -196,386 |